The Food and Drug Administration voted on Friday to recommend Pfizer-BioNTech's COVID-19 vaccine for kids ages 5 to 11. The FDA cleared the use of child-sized doses, which contain just a third of the amount given to teens and adults. The FDA's vote paves the way for emergency use authorization, but the CDC will make a more detailed recommendation next week. A final decision is expected shortly after. If approved, nearly 28 million American children could be eligible for vaccinations beginning in November. Earlier this week, Moderna announced its vaccine was safe for children ages six to 11. Neither Moderna nor Johnson & Johnson shots have been approved for children or teens. Adolescents ages 12 to 17 have been eligible to receive the Pfizer vaccine since its approval in May.